Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Miners, Drug Makers And VW Drive FTSE 100 Lower

Tue, 22nd Sep 2015 11:17

LONDON (Alliance News) - UK shares were lower Tuesday midday, with commodity-related and pharmaceutical stocks the leading blue-chip fallers.

Only one FTSE 100 stock was in the green Tuesday, RSA Insurance, rebounding 1.5% after having lost 21% on Monday after Zurich Insurance pulled out of takeover talks.

The FTSE 100 was down 1.9% at 5,994,67, trading below the 6,000 line for the first time in nearly a month. The FTSE 250 index was off 1.5% at 16,640.03, and the AIM All-Share was down 0.9% at 732.97. In Europe, the CAC 40 index in Paris was down 3.0% and the DAX 30 in Frankfurt was declining 2.7%.

Stocks in Asia closed higher, with the Hang Seng index up 0.2% and the Shanghai Composite up 0.9%. The Japanese market remains closed for holiday until Thursday.

Wall Street was called for a negative open, as analysts expect global growth concerns and uncertainty over US interest rates to continue to weigh on investor confidence. US stock futures were pointed down, with the Dow 30 index seen down 1.5%, the S&P 500 off 1.6% and the Nasdaq 100 called down 1.9%.

Ahead in the US economic calendar, there is the US Redbook index at 1355 BST just before the housing price index at 1400 BST.

Oanda analyst Craig Erlam said that the absence of economic data isn't helping to lift risk appetite in the market, "with investors needing some form of positive catalyst to lift the mood".

"Ordinarily, the prospect of US interest rates staying lower for longer could have prompted such a positive response, but such is the environment we currently find ourselves in, investors instead focused on the downbeat growth and inflation forecasts and emerging markets risks," Erlam said.

In London, miners were amongst the worst performers in the blue-chip index after downgrades from Credit Suisse and lower commodity prices.

Antofagasta was down 7.1% after the bank cut it to Underperform from Neutral, while Anglo American was down 6.8% after being cut to Neutral from Outperform. Others such as Glencore, down 8.8%, BHP Billiton, down 4.5%, and Rio Tinto, down 4.1%, also were among the biggest fallers.

Head of Research at Accendo Markets Mike van Dulken said that the strength of the dollar following Thursday's US Federal Reserve decision to keep US interest rates on hold was hurting the price of commodities. As a result, gold prices retreated Tuesday to USD1,130.50, while silver also was taking a step back to USD14.98.

Other commodities such as oil were being sold as well. Brent oil prices were down at USD48.10 a barrel, coming off the level of USD50.31 prior to the Fed decision, while West Texas Intermediate was at USD45.93 a barrel, having traded at USD47.68 before the Fed announcement.

Consequently, oil-related stocks also were in the red, with BP down 2.8%, Royal Dutch Shell 'B' share down 2.6% and BG Group down 2.4%.

The pound was lower against the dollar Tuesday, standing at USD1.5442, having traded at USD1.5558 before the Fed decision on Thursday.

Pharmaceutical companies were out of favour, with Shire down 4.0%, AstraZeneca down 3.5% and GlaxoSmithKline down 3.0%, after US presidential candidate Hillary Clinton tweeted about "price gouging" in the specialty drug market.

On her official twitter account Monday, Clinton cited a New York Times article which said the price of the Daraprim drug, which treats a life-threatening parasitic infection, soared to USD750 a tablet from USD13.50 a tablet overnight.

Clinton, the frontrunner for the Democratic nomination, tweeted "price gouging like this in the specialty drug market is outrageous. Tomorrow I'll lay out a plan to take it on".

Meanwhile, analysts at UBS suggested that GKN, down 5.1%, could be retreating as shares in Volkswagen crashed again on Tuesday amid an emissions cheating scandal. Volkswagen is GKN's largest customer in its Driveline business.

The German carmaker issued a third-quarter profit warning and admitted that emissions tests for about 11 million cars around the world may have been manipulated. Europe's biggest carmaker said it is setting aside EUR6.5 billion to cover costs of the investigation into how software was used to cheat emissions tests.

Meanwhile, J Sainsbury, down 0.4%, jumped briefly into the green before giving back its gains, after Kantar Worldpanel's grocery market survey said that it was the only big four UK supermarket to increase sales in the past 12 weeks, for the second consecutive period.

Sainsbury's sales rose 0.9% in the 12 weeks to September 13 to GBP4.01 billion from GBP3.97 billion in the same period a year earlier, as its market share stayed flat at 16.2%.

Shares were down among Sainburys' blue-chip peers, whose sales Kantar said were lower, with Wm Morrison Supermarkets down 1.6% and Tesco off 1.4%.

In the FTSE 250, IG Group Holdings was the best performer, up 2.7% after it said its revenue increased substantially in the first quarter against a weak comparative, but said the volatile market conditions make it difficult to predict an outcome for the full year.

The spread betting and contracts-for-difference company, which gives retail traders access to financial markets, said it is trading in line with its expectations at present, with revenue in the first quarter to the end of August up 24% to GBP106.0 million, though it noted the same period last year was "particularly subdued".

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.